AMAG Pharmaceuticals, Inc.

United States of America

 
Total IP 3
Total IP incl. subs 129 (+ 126 for subs)
Total IP Rank # 503,007
IP Activity Score 0/5.0    0
IP Activity Rank # 1,661,095
IP AS incl. subs 2.3/5.0    58
Stock Symbol AMAG (nasdaq)
ISIN US00163U1060
Market Cap. 473M  (USD)
Industry Biotechnology
Sector Healthcare

Patents

Trademarks

0 0
0 0
3 0
0
 
Last Patent 2017 - Polymeric extended release compo...
First Patent 1988 - Vascular magnetic imaging method...

Subsidiaries

4 subsidiaries with IP (88 patents, 38 trademarks)

1 subsidiaries without IP

 Register for free to unlock the subsidiary list

Latest Inventions, Goods, Services

2017 Invention Polymeric extended release compositions of hydroxyprogesterone caproate and methods of using same...
2016 Invention Crystalline and amorphous form of 17-a- hydroxyprogesterone caproate. The disclosure is in part d...
2014 Invention Macrophage-enhanced mri (memri) in a single imaging session. Methods for performing macrophage-e...
Invention Polyol and polyether iron oxide complexes as pharmacological and/or mri contrast agents. Iron oxi...
2010 Invention Polyol and polyether iron oxide complexes as pharmacological and/or mri contrast agents. Pharmaco...
2008 Invention Macrophage-enhanced mri (memri). Methods for assessing stage of cancer in a subject are provided,...
Invention Macrophage-enhanced mri (memri). Methods for assessing stage of cancer in a subject are provided...
2002 Invention Liquid formulations for the prevention and treatment of mucosal diseases and disorders. Stable, v...
1996 Invention Polymeric carriers linked to nucleotide analogues via a phosphoramide bond. Novel compositions of...
1995 Invention Hepatocyte-specific receptor-mediated endocytosis-type compositions. A new class of magnetic reso...
1994 Invention Endotoxin-free polysaccharides. This invention is composition comprising a highly purified, subst...
Invention Delivery of therapeutic agents to receptors using polysaccharides. This invention relates to a me...
1993 Invention Directed delivery of radioprotectants using a receptor specific carrier. Chemoactive radioprotect...
1992 Invention Vascular magnetic resonance imaging agent comprising nanoparticles. The preparation and isolation...
Invention Targeting of therapeutic agents using polysaccharides. The invention relates to a method for the ...
Invention Receptor mediated endocytosis type magnetic resonance imaging contrast agents. A new class of mag...
Invention Hepatocyte specific composition and their use as diagnostic imaging agents. A new class of magnet...
Invention Arabinogalactan derivatives and uses thereof. A substantially purified arabinogalactan, its degra...
Invention Hydrated biodegradable superparamagnetic metal oxides. This invention relates to materials exhibi...
Invention Low molecular weight carbohydrates as additives to stabilize metal oxide compositions. This inven...
1991 Invention Synthesis of polysaccharide covered superparamagnetic oxide colloids. In a method for the synthes...
Invention Filter sterilization for production of colloidal, superparamagnetic mr contrast agents. An improv...
1989 Invention Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastro...
1988 Invention Biodegradable superparamagnetic metal oxides as contrast agents for mr imaging. This invention re...
Invention Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxid...